{
    "medicine_id": "0ba3ec2bfd97d9ad3e1a4630548fbb77845e8049",
    "platform_id": "DB00513",
    "metadata": {
        "name": "28tak Gum Care Tooth 250 mg 1mL Injection solution",
        "composition": "250 mg 1mL Aminocaproic acid",
        "clinical_particulars": {
            "therapeutic_indications": "For use in the treatment of excessive postoperative bleeding",
            "contraindications": {
                "disease": "A few cases of acute overdosage with intravenous administration have been reported The effects have ranged from no reaction to transient hypotension to severe acute renal failure leading to death The intravenous and oral LD sub 50 sub were 3 0 and 12 0 g kg respectively in the mouse and 3 2 and 16 4 g kg respectively in the rat An intravenous infusion dose of 2 3 g kg was lethal in the dog",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Aminocaproic acid works as an antifibrinolytic It is a derivative of the amino acid lysine The fibrinolysis inhibitory effects of aminocaproic acid appear to be exerted principally via inhibition of plasminogen activators and to a lesser degree through antiplasmin activity Aminocaproic acid may be a possible prophylactic for vascular disease as it may prevent formation of lipoprotein a a risk factor for vascular disease",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00058",
                        "description": "Alpha 1 proteinase inhibitor may increase the thrombogenic activities of Aminocaproic acid"
                    },
                    {
                        "drugbank-id": "DB00170",
                        "description": "Menadione may increase the thrombogenic activities of Aminocaproic acid"
                    },
                    {
                        "drugbank-id": "DB00302",
                        "description": "Tranexamic acid may increase the thrombogenic activities of Aminocaproic acid"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "Aminocaproic acid may increase the thrombogenic activities of Aprotinin"
                    },
                    {
                        "drugbank-id": "DB11091",
                        "description": "Aminocaproic acid may increase the thrombogenic activities of Hydrogen peroxide"
                    },
                    {
                        "drugbank-id": "DB13244",
                        "description": "Aminocaproic acid may increase the thrombogenic activities of Aminomethylbenzoic acid"
                    },
                    {
                        "drugbank-id": "DB13729",
                        "description": "Aminocaproic acid may increase the thrombogenic activities of Camostat"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of Thrombosis can be increased when Tretinoin is combined with Aminocaproic acid"
                    },
                    {
                        "drugbank-id": "DB00025",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor human recombinant"
                    },
                    {
                        "drugbank-id": "DB00036",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor VIIa Recombinant Human"
                    },
                    {
                        "drugbank-id": "DB00100",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation Factor IX Recombinant"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium acetate"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium chloride"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium"
                    },
                    {
                        "drugbank-id": "DB01783",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Pantothenic acid"
                    },
                    {
                        "drugbank-id": "DB01942",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Formic acid"
                    },
                    {
                        "drugbank-id": "DB02261",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Platelet Activating Factor"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB09109",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Turoctocog alfa"
                    },
                    {
                        "drugbank-id": "DB09222",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Fibrinogen human"
                    },
                    {
                        "drugbank-id": "DB09310",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Catridecacog"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic Factor Recombinant PEGylated"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium gluconate"
                    },
                    {
                        "drugbank-id": "DB11168",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium threonate"
                    },
                    {
                        "drugbank-id": "DB11311",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Prothrombin"
                    },
                    {
                        "drugbank-id": "DB11330",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Factor IX Complex Human"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium Phosphate"
                    },
                    {
                        "drugbank-id": "DB11606",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Susoctocog alfa"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Eftrenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB11668",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Rusalatide acetate"
                    },
                    {
                        "drugbank-id": "DB12409",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Vatreptacog alfa"
                    },
                    {
                        "drugbank-id": "DB12909",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Factor XIII human"
                    },
                    {
                        "drugbank-id": "DB13133",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Von Willebrand Factor Human"
                    },
                    {
                        "drugbank-id": "DB13148",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor X human"
                    },
                    {
                        "drugbank-id": "DB13150",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor VII human"
                    },
                    {
                        "drugbank-id": "DB13151",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Anti inhibitor coagulant complex"
                    },
                    {
                        "drugbank-id": "DB13152",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation Factor IX Human"
                    },
                    {
                        "drugbank-id": "DB13192",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor human"
                    },
                    {
                        "drugbank-id": "DB13197",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Kallidinogenase"
                    },
                    {
                        "drugbank-id": "DB13201",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Trenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Albutrepenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Emicizumab"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Nonacog beta pegol"
                    },
                    {
                        "drugbank-id": "DB13999",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Moroctocog alfa"
                    },
                    {
                        "drugbank-id": "DB14473",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Beroctocog alfa"
                    },
                    {
                        "drugbank-id": "DB14562",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Andexanet alfa"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Calcium cation"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Damoctocog alfa pegol"
                    },
                    {
                        "drugbank-id": "DB14738",
                        "description": "The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Turoctocog alfa pegol"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}